Biodesix Inc (BDSX): Total Liabilities
$89.94M
As of 2025-12-31
$86.18M
As of 2026-06-30
+7.5%
3-year compound annual growth
+2.4%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $89.94M | +17.8% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $76.37M | -19.2% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $94.52M | +30.7% | 2025-03-03, Balance as of period end |
| 2022-12-31 | $72.30M | +28.3% | 2024-03-01, Balance as of period end |
| 2021-12-31 | $56.37M | -29.5% | 2023-03-06, Balance as of period end |
| 2020-12-31 | $79.90M | +4.8% | 2022-03-14, Balance as of period end |
| 2019-12-31 | $76.21M | n/a | 2021-03-16, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Biodesix Inc (BDSX) | 2025-12-31 | $89.94M | +17.8% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $72.98M | +8.4% |
| Exagen Inc. (XGN) | 2025-12-31 | $40.57M | +15.4% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $344.15M | -28.3% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $27.79M | -7.9% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $152.55M | +13.6% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $106.81M | +17.6% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $107.68M | +42.8% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $110.13M | -2.2% |
Compare BDSX, PSNL, XGN, GRAL side by side · Screen every company in Services-Medical Laboratories ↗